HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ... Nature 535 (7613), 556-560, 2016 | 477 | 2016 |
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1 T Schoofs, F Klein, M Braunschweig, EF Kreider, A Feldmann, L Nogueira, ... Science 352 (6288), 997-1001, 2016 | 339 | 2016 |
Prediction of HIV-1 sensitivity to broadly neutralizing antibodies shows a trend towards resistance over time A Hake, N Pfeifer PLoS computational biology 13 (10), e1005789, 2017 | 33 | 2017 |
Patterns of amino acid conservation in human and animal immunodeficiency viruses OS Voitenko, A Dhroso, A Feldmann, D Korkin, OV Kalinina Bioinformatics 32 (17), i685-i692, 2016 | 10 | 2016 |
From predicting to analyzing HIV-1 resistance to broadly neutralizing antibodies A Feldmann, N Pfeifer PeerJ PrePrints, 2015 | 2 | 2015 |
Dynamics and durability of HIV-1 neutralization are determined by viral replication P Schommers, DS Kim, M Schlotz, C Kreer, R Eggeling, A Hake, ... Nature Medicine 29 (11), 2763-2774, 2023 | 1 | 2023 |
Insights to HIV-1 coreceptor usage by estimating HLA adaptation with Bayesian generalized linear mixed models A Hake, A Germann, C de Beer, A Thielen, M Däumer, W Preiser, ... bioRxiv, 2022.07. 06.498925, 2022 | 1 | 2022 |
Predicting and analyzing HIV-1 adaptation to broadly neutralizing antibodies and the host immune system using machine learning A Hake Saarländische Universitäts-und Landesbibliothek, 2022 | | 2022 |
Predicting HIV-1 Susceptibility to Broadly Neutralizing Antibodies A Feldmann Universität des Saarlandes Saarbrücken, 2014 | | 2014 |